Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives

Heit, 2005, Venous thromboembolism: disease burden, outcomes and risk factors., J Thromb Haemost, 3, 1611, 10.1111/j.1538-7836.2005.01415.x White, 2003, The epidemiology of venous thromboembolism., Circulation, 107, I4, 10.1161/01.CIR.0000078468.11849.66 Chan, 2008, Hypercoagulable states in cardiovascular disease., Circulation, 118, 2286, 10.1161/CIRCULATIONAHA.108.778837 Reitsma, 2007, Past and future of genetic research in thrombosis., J Thromb Haemost, 5, 264, 10.1111/j.1538-7836.2007.02502.x Noboa, 2008, Family history as a risk factor for venous thromboembolism., Thromb Res, 122, 624, 10.1016/j.thromres.2007.12.026 Scott, 2004, Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease., Arterioscler Thromb Vasc Biol, 24, 1558, 10.1161/01.ATV.0000136649.83297.bf Undas, 2007, Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress., Atherosclerosis, 196, 551, 10.1016/j.atherosclerosis.2007.05.028 Fatah, 1992, Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis., Thromb Haemost, 68, 130, 10.1055/s-0038-1656337 Collet, 2006, Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis., Arterioscler Thromb Vasc Biol, 26, 2567, 10.1161/01.ATV.0000241589.52950.4c Undas, 2009, Altered fibrin clot structure/function as a novel risk factor for cryptogenic ischemic stroke., Stroke, 40, 1499, 10.1161/STROKEAHA.108.532812 Curnow, 2007, Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay., J Thromb Haemost, 5, 528, 10.1111/j.1538-7836.2007.02362.x Cushman, 2003, Fibrin fragment D-dimer and the risk of future venous thrombosis., Blood, 101, 1243, 10.1182/blood-2002-05-1416 Lisman, 2005, Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis., Blood, 105, 1102, 10.1182/blood-2004-08-3253 Mills, 2002, Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease., Circulation, 106, 1938, 10.1161/01.CIR.0000033221.73082.06 Undas, 2008, Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality., Nephrol Dial Transplant, 23, 2010, 10.1093/ndt/gfm884 Blombäck, 1989, Native fibrin gel networks observed by 3D microscopy, permeation and turbidity., Biochim Biophys Acta, 997, 96, 10.1016/0167-4838(89)90140-4 Undas, 2006, Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease., J Thromb Haemost, 4, 1029, 10.1111/j.1538-7836.2006.01882.x Collet, 1999, Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications., Thromb Haemost, 82, 1482 Balogh, 2000, Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia., Blood, 96, 2479, 10.1182/blood.V96.7.2479 Carter, 2000, Alpha fibrinogen Thr312Ala polymorphism and venous thromboembolism., Blood, 96, 1177, 10.1182/blood.V96.3.1177 Wichers, 2009, Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia., Thromb Haemost, 101, 465, 10.1160/TH08-06-0405 Prandoni, 2003, An association between atherosclerosis and venous thrombosis., N Engl J Med, 348, 1435, 10.1056/NEJMoa022157 Braekkan, 2008, Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study., J Thromb Haemost, 6, 1851, 10.1111/j.1538-7836.2008.03102.x Carter, 2007, Heritability of clot formation, morphology, and lysis: the EuroCLOT Study., Arterioscler Thromb Vasc Biol, 27, 2783, 10.1161/ATVBAHA.107.153221 Undas, 2006, Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects., Arterioscler Thromb Vasc Biol, 26, 1397, 10.1161/01.ATV.0000219688.43572.75 Wolberg, 2007, Thrombin generation and fibrin clot structure., Blood Rev, 21, 131, 10.1016/j.blre.2006.11.001 Tripodi, 2007, The endogenous thrombin potential and the risk of venous thromboembolism., Thromb Res, 121, 353, 10.1016/j.thromres.2007.04.012 Ariëns, 2000, The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure., Blood, 96, 988, 10.1182/blood.V96.3.988 Standeven, 2003, Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function., Circulation, 107, 2326, 10.1161/01.CIR.0000066690.89407.CE Ajjan, 2009, Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system., Arterioscler Thromb Vasc Biol, 29, 712, 10.1161/ATVBAHA.109.183707 Undas, 2009, Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3. 4 mmol/l., Pol Arch Med Wewn, 119, 354 Weisel, 2008, The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate., Cardiovasc Hematol Agents Med Chem, 6, 161, 10.2174/187152508784871963 Undas, 2006, Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis., J Thromb Haemost, 4, 973, 10.1111/j.1538-7836.2006.01903.x